Lingyun Ji

7.4k total citations · 1 hit paper
130 papers, 3.5k citations indexed

About

Lingyun Ji is a scholar working on Public Health, Environmental and Occupational Health, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Lingyun Ji has authored 130 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Public Health, Environmental and Occupational Health, 28 papers in Pulmonary and Respiratory Medicine and 27 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Lingyun Ji's work include Acute Lymphoblastic Leukemia research (28 papers), Childhood Cancer Survivors' Quality of Life (26 papers) and Neuroblastoma Research and Treatments (21 papers). Lingyun Ji is often cited by papers focused on Acute Lymphoblastic Leukemia research (28 papers), Childhood Cancer Survivors' Quality of Life (26 papers) and Neuroblastoma Research and Treatments (21 papers). Lingyun Ji collaborates with scholars based in United States, Canada and China. Lingyun Ji's co-authors include Richard Sposto, Susan Groshen, Mignon L. Loh, Elizabeth A. Raetz, Bhushan Desai, Jonathan L. Finlay, Hossein Jadvar, David I. Quinn, Hiroyuki Shimada and Richard H. Ko and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Lingyun Ji

123 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia

2021 207 citations Patrick A. Brown, Lingyun Ji et al. profile →

Peers

Countries citing papers authored by Lingyun Ji

Since Specialization

Citations

This map shows the geographic impact of Lingyun Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyun Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyun Ji more than expected).

Fields of papers citing papers by Lingyun Ji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingyun Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyun Ji. The network helps show where Lingyun Ji may publish in the future.

Co-authorship network of co-authors of Lingyun Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Lingyun Ji. A scholar is included among the top collaborators of Lingyun Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyun Ji. Lingyun Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	T-cell dysfunction during blinatumomab therapy in pediatric acute lymphoblastic leukemia 2025 ·Blood Advances ·(unknown), Annie Luong, Andrew Doan, (unknown), Lingyun Ji, (unknown), (unknown), Teresa Rushing, Phuong-Anh T. Duong, (unknown), Chintan Parekh	1
2	On the use of external controls in clinical trials 2025 ·JNCI Monographs ·(unknown), Stephanie L. Pugh, Lingyun Ji, Jin Piao, James J. Dignam, Jon A. Steingrimsson	0
3	Population-Based Data Linkage Describing Patterns of Cancer Clinical Trial Enrollment Among Children and Adolescents 2024 ·JCO Oncology Practice ·David A. Siegel, Eric B. Durbin, Brad H. Pollock, (unknown), Lingyun Ji, Todd A. Alonzo, Sarah Vargas, Bin Huang, (unknown), (unknown), (unknown), Eric Tai, Michael Roth, David R. Freyer	0
4	Loss to follow‐up of minorities, adolescents, and young adults on clinical trials: A report from the Children's Oncology Group 2023 ·Cancer ·(unknown), Lingyun Ji, Xinxin Xu, Michael Roth, David R. Freyer, A. Lindsay Frazier, Asher Marks, Farzana Pashankar	13
5	Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse 2023 ·Journal of Clinical Oncology ·Laura Hogan, Patrick A. Brown, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Teena Bhatla, Michael J. Borowitz, Elizabeth A. Raetz, Andrew J. Carroll, Nyla A. Heerema, Gerhard Zugmaier, Elad Sharon, M. Brooke Bernhardt, Stephanie Terezakis, Lia Gore, James A. Whitlock, Stephen P. Hunger, Mignon L. Loh	33
6	Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children’s Oncology Group experience 2022 ·Bone Marrow Transplantation ·Jeffrey R. Andolina, Yi‐Cheng Wang, Lingyun Ji, David R. Freyer, John E. Levine, Michael A. Pulsipher, Alan S. Gamis, Richard Aplenc, Michael Roth, Lauren Harrison, Mitchell S. Cairo	6
7	A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in Low Risk (LR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs): A Report from Children's Oncology Group Study AALL1331 2021 ·Blood ·Patrick A. Brown, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Laura Hogan, Teena Bhatla, Michael J. Borowitz, Elizabeth A. Raetz, Lia Gore, James A. Whitlock, Stephen P. Hunger, Mignon L. Loh	7
8	Pediatric oncology clinician communication about sexual health with adolescents and young adults: A report from the children’s oncology group 2021 ·Cancer Medicine ·Natasha N. Frederick, Kristin Bingen, Sharon L. Bober, Brooke Cherven, Xinxin Xu, Gwendolyn P. Quinn, Lingyun Ji, David R. Freyer	13
9	Development of a Risk Model for Pediatric Hospital-Acquired Thrombosis: A Report from the Children's Hospital-Acquired Thrombosis Consortium 2020 ·The Journal of Pediatrics ·Julie Jaffray, Brian R. Branchford, Neil A. Goldenberg, Jemily Malvar, Stacy E. Croteau, (unknown), John H. Fargo, James Cooper, Nihal Bakeer, Richard Sposto, Lingyun Ji, Neil A. Zakai, E. Vincent S. Faustino, (unknown), (unknown), Guy Young, Arash Mahajerin	25
10	A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk (HR/IR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs) Demonstrates Superior Efficacy and Tolerability of Blinatumomab: A Report from Children's Oncology Group Study AALL1331 2019 ·Blood ·Patrick A. Brown, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Laura Hogan, Michael J. Borowitz, Elizabeth A. Raetz, Gerhard Zugmaier, Elad Sharon, Lia Gore, James A. Whitlock, Michael A. Pulsipher, Stephen P. Hunger, Mignon L. Loh	51
11	Predictors of response, progression‐free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high‐risk neuroblastoma 2018 ·Pediatric Blood & Cancer ·Judith G. Villablanca, Lingyun Ji, (unknown), Araz Marachelian, Hiroyuki Shimada, Randall A. Hawkins, Miguel Hernandez Pampaloni, Hollie Lai, Fariba Goodarzian, Richard Sposto, Julie R. Park, Katherine K. Matthay	7
12	No Acute Changes in LVEF Observed With Concurrent Trastuzumab and Breast Radiation With Low Heart Doses 2017 ·Clinical Breast Cancer ·Shelly X. Bian, (unknown), (unknown), Lingyun Ji, Susan Groshen, Eugene H. Chung	10
13	Effect of Compound Cortex Phellodendri Fluid on AGEs and Inflammatory Factors in Promoting Healing Process of Diabetic Foot Ulcer 2016 ·(unknown), Youshan Li, Lingyun Ji	1
14	Survival Outcomes for Patients With 5+ Versus Single or 2 to 4 Brain Metastases Undergoing Stereotactic Radiosurgery (SRS) 2015 ·International Journal of Radiation OncologyBiologyPhysics ·David M. Routman, Shelly X. Bian, Lingyun Ji, Susan Groshen, Michael L.J. Apuzzo, Cheng Yu, Eric L. Chang	1
15	Critical Role of STAT3 in IL-6–Mediated Drug Resistance in Human Neuroblastoma 2013 ·Cancer Research ·Tasnim Ara, Rie Nakata, Michael A. Sheard, Hiroyuki Shimada, Ralf Buettner, Susan Groshen, Lingyun Ji, Hua Yu, Richard Jove, Robert C. Seeger, Yves A. DeClerck	105
16	PID1 ( NYGGF4 ), a New Growth-Inhibitory Gene in Embryonal Brain Tumors and Gliomas 2013 ·Clinical Cancer Research ·Anat Erdreich‐Epstein, Nathan Robison, Xiuhai Ren, Hong Zhou, Jingying Xu, Tom B. Davidson, (unknown), Floyd H. Gilles, Lingyun Ji, Jemily Malvar, Gregory M. Shackleford, Ashley Margol, Mark D. Krieger, Alexander R. Judkins, David Jones, Stefan M. Pfister, Marcel Kool, Richard Sposto, (unknown)	26
17	Infectious Morbidity by Catheter Type in Neutropenic Children With Cancer 2013 ·The Pediatric Infectious Disease Journal ·Etan Orgel, Lingyun Ji, William A. Pastor, Reuven J. Schore	10
18	Current Treatment Protocols Have Eliminated the Prognostic Advantage of Type 1 Fusions in Ewing Sarcoma: A Report From the Children's Oncology Group 2010 ·Journal of Clinical Oncology ·(unknown), Lingyun Ji, (unknown), Hiroyuki Shimada, Michele R. Wing, Mark Krailo, Stephen L. Lessnick, Neyssa Marina, Timothy J. Triche, Richard Sposto, Richard B. Womer, Elizabeth R. Lawlor	95
19	Sodium Thiosulfate Administered Six Hours after Cisplatin Does Not Compromise Antineuroblastoma Activity 2008 ·Clinical Cancer Research ·(unknown), Ondrej Kalous, Alexander Neuwelt, (unknown), Lingyun Ji, Peter M. Iovine, Richard Sposto, Edward A. Neuwelt, C. Patrick Reynolds	50
20	Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature. 2004 ·PubMed ·(unknown), Bhushan Desai, Lingyun Ji, Susan Groshen, Hossein Jadvar	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact